Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Goldcal-Max is a multi-ingredient nutritional supplement and branded generic pharmaceutical product developed by Ronyd Healthcare. It is primarily formulated to support bone health and manage conditions such as osteoporosis, osteomalacia, and calcium deficiency. The formulation typically contains a combination of **calcitriol** (the active form of vitamin D3), **calcium carbonate**, and essential minerals including **zinc**, **magnesium**, and **boron**, alongside vitamins such as **methylcobalamin** (vitamin B12) and **folic acid**. Calcitriol acts as a potent agonist of the vitamin D receptor, enhancing the intestinal absorption of calcium and phosphate. Calcium carbonate provides the elemental calcium necessary for bone mineralization, while the additional minerals and vitamins serve as enzymatic cofactors and structural components that support bone density and overall metabolic health. Goldcal-Max is typically administered orally in a softgel capsule format.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Goldcal-Max.